353 related articles for article (PubMed ID: 24399346)
1. [Antimicrobial resistance in tuberculosis].
Gutiérrez-Aroca JB; Ruiz P; Casal M
Rev Esp Quimioter; 2013 Dec; 26(4):332-6. PubMed ID: 24399346
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of Drug-Resistant Tuberculosis in Spain (2001-2015).
Gutiérrez-Aroca JB; Ruiz P; Vaquero M; Causse M; Casal M
Microb Drug Resist; 2018; 24(6):839-843. PubMed ID: 29608388
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC
Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195
[TBL] [Abstract][Full Text] [Related]
4. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
El-Sayed Zaki M; Goda T
Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
7. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
[TBL] [Abstract][Full Text] [Related]
8. The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
Lu PL; Lee YW; Peng CF; Tsai JJ; Chen YH; Hwang KP; Chen TP
Int J Antimicrob Agents; 2003 Mar; 21(3):239-43. PubMed ID: 12636985
[TBL] [Abstract][Full Text] [Related]
9. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
Kobayashi I; Abe C; Mitarai S
Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006
[TBL] [Abstract][Full Text] [Related]
10. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
[TBL] [Abstract][Full Text] [Related]
11. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z
Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231
[TBL] [Abstract][Full Text] [Related]
12. [Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens].
Aydın F; Kaklıkkaya N; Bayramoğlu G; Ozkul G; Buruk K; Dinç U; Köse T; Dede R
Mikrobiyol Bul; 2011 Jan; 45(1):36-42. PubMed ID: 21341157
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of the action of drugs in the short-course chemotherapy].
Mitchison DA
Bull Int Union Tuberc; 1985; 60(1-2):36-40. PubMed ID: 2416374
[No Abstract] [Full Text] [Related]
14. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Dickinson JM; Aber VR; Mitchison DA
Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
[TBL] [Abstract][Full Text] [Related]
16. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
[TBL] [Abstract][Full Text] [Related]
17. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Al-Marri MR
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
[TBL] [Abstract][Full Text] [Related]
18. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
19. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study.
Kontos F; Maniati M; Costopoulos C; Gitti Z; Nicolaou S; Petinaki E; Anagnostou S; Tselentis I; Maniatis AN
J Microbiol Methods; 2004 Feb; 56(2):291-4. PubMed ID: 14744458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]